Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitors.
Gefard-Gontier E, Markich R, Zysman M, Veillon R, Daste A, Domblides C, Sionneau B, Gross-Goupil M, Lefort F, Prey S, Dutriaux C, Gerard E, Dousset L, Pham-Ledard A, Beylot-Barry M, Schaeverbeke T, Kostine M.
Gefard-Gontier E, et al. Among authors: kostine m.
Cancer Immunol Immunother. 2022 Nov;71(11):2609-2618. doi: 10.1007/s00262-022-03180-x. Epub 2022 Mar 19.
Cancer Immunol Immunother. 2022.
PMID: 35305123
Free PMC article.